DOCSLIB.ORG

Download (PDF)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Download (PDF) Tomono et al.: Glycan evolution based on phylogenetic profiling 1 Supplementary Table S1. List of 173 enzymes that are composed of glycosyltransferases and functionally-linked glycan synthetic enzymes UniProt ID Protein Name Categories of Glycan Localization CAZy Class 1 Q8N5D6 Globoside -1,3-N -acetylgalactosaminyltransferase 1 Glycosphingolipid Golgi apparatus GT6 P16442 Histo-blood group ABO system transferase Glycosphingolipid Golgi apparatus GT6 P19526 Galactoside 2--L-fucosyltransferase 1 Glycosphingolipid Golgi apparatus GT11 Q10981 Galactoside 2--L-fucosyltransferase 2 Glycosphingolipid Golgi apparatus GT11 Q00973 -1,4 N -acetylgalactosaminyltransferase 1 Glycosphingolipid Golgi apparatus GT12 Q8NHY0 -1,4 N -acetylgalactosaminyltransferase 2 O -Glycan, N -Glycan, Glycosphingolipid Golgi apparatus GT12 Q09327 -1,4-mannosyl-glycoprotein 4--N -acetylglucosaminyltransferase N -Glycan Golgi apparatus GT17 Q09328 -1,6-mannosylglycoprotein 6--N -acetylglucosaminyltransferase A N -Glycan Golgi apparatus GT18 Q3V5L5 -1,6-mannosylglycoprotein 6--N -acetylglucosaminyltransferase B O -Glycan, N -Glycan Golgi apparatus GT18 Q92186 -2,8-sialyltransferase 8B (SIAT8-B) (ST8SiaII) (STX) N -Glycan Golgi apparatus GT29 O15466 -2,8-sialyltransferase 8E (SIAT8-E) (ST8SiaV) Glycosphingolipid Golgi apparatus GT29 P61647 -2,8-sialyltransferase 8F (SIAT8-F) (ST8SiaVI) O -Glycan Golgi apparatus GT29 Q9NSC7 -N -acetylgalactosaminide -2,6-sialyltransferase 1 (ST6GalNAcI) (SIAT7-A) O -Glycan Golgi apparatus GT29 Q9UJ37 -N -acetylgalactosaminide -2,6-sialyltransferase 2 (ST6GalNAcII) (SThM) (SIAT7-B) O -Glycan Golgi apparatus GT29 Q8NDV1 -N -acetylgalactosaminide -2,6-sialyltransferase 3 (ST6GalNAcIII) (SIAT7-C) Glycosphingolipid Golgi apparatus GT29 Q9BVH7 -N -acetylgalactosaminide -2,6-sialyltransferase 5 (ST6GalNAcV) (SIAT7-E) Glycosphingolipid Golgi apparatus GT29 Q969X2 -N -acetylgalactosaminide -2,6-sialyltransferase 6 (ST6GalNAcVI) (SIAT7-F) Glycosphingolipid Golgi apparatus GT29 Q92185 -N -acetylneuraminide -2,8-sialyltransferase (Ganglioside GD3 synthase) (SIAT8-A) (ST8SiaI) Glycosphingolipid Golgi apparatus GT29 -N -acetyl-neuraminyl-2,3--galactosyl-1,3-N -acetyl-galactosaminide -2,6-sialyltransferase Q9H4F1 Glycosphingolipid Golgi apparatus GT29 (ST6GalNAcIV) (SIAT3-C) (SIAT7-D) P15907 -galactoside -2,6-sialyltransferase 1 (ST6GalI) O -Glycan, N -Glycan Golgi apparatus GT29 Q96JF0 -galactoside -2,6-sialyltransferase 2 (ST6GalII) O -Glycan, N -Glycan Golgi apparatus GT29 Q11203 CMP-N -acetylneuraminate--1,4-galactoside -2,3-sialyltransferase (ST3GalIII) (Sialyltransferase 6) O -Glycan, Glycosphingolipid, Proteoglycan Golgi apparatus GT29 Q11201 CMP-N -acetylneuraminate--galactosamide--2,3-sialyltransferase 1 (ST3GalI) (SIAT4-A) O -Glycan, Glycosphingolipid, Proteoglycan Golgi apparatus GT29 Q16842 CMP-N -acetylneuraminate--galactosamide--2,3-sialyltransferase 2 (ST3GalII) (SIAT4-B) O -Glycan, Glycosphingolipid, Proteoglycan Golgi apparatus GT29 Q11206 CMP-N -acetylneuraminate--galactosamide--2,3-sialyltransferase 4 (ST3GalIV) (STZ) (SIAT4-C) Glycosphingolipid Golgi apparatus GT29 Q92187 CMP-N -acetylneuraminate-poly--2,8-sialyltransferase (SIAT8-D) (ST8SiaIV) N -Glycan Golgi apparatus GT29 Q9UNP4 Lactosylceramide -2,3-sialyltransferase (Ganglioside GM3 synthase) (ST3GalV) (Sialyltransferase 9) Glycosphingolipid Golgi apparatus GT29 O43173 Sia--2,3-Gal--1,4-GlcNAc-R: 2,8-sialyltransferase (SIAT8-C) (ST8SiaIII) N -Glycan, Glycosphingolipid Golgi apparatus GT29 Q9Y274 Type 2 lactosamine -2,3-sialyltransferase (ST3GalVI) (Sialyltransferase 10) Glycosphingolipid Golgi apparatus GT29 Q9UNA3 -1,4-N -acetylglucosaminyltransferase O -Glycan Golgi apparatus GT32 Q9NPC4 Lactosylceramide 4--galactosyltransferase Glycosphingolipid Golgi apparatus GT32 Q8NAT1 Glycosyltransferase-like domain-containing protein 2 O -Glycan Extracellular GT61 O94777 Dolichol phosphate-mannose biosynthesis regulatory protein N -Glycan, GPI anchor Endoplasmic reticulum - Q9P2X0 Dolichol-phosphate mannosyltransferase subunit 3 N -Glycan Endoplasmic reticulum - P0C6T2 Dolichyl-diphosphooligosaccharideprotein glycosyltransferase subunit 4 N -Glycan Endoplasmic reticulum - Q3MUY2 Phosphatidylinositol N -acetylglucosaminyltransferase subunit Y GPI anchor Endoplasmic reticulum - Q8TBF5 Phosphatidylinositol-glycan biosynthesis class X protein GPI anchor Endoplasmic reticulum - Endoplasmic reticulum, Cytoplasm, Q14442 Phosphatidylinositol N -acetylglucosaminyltransferase subunit H GPI anchor - Mitochondria, Nucleus O75072 Fukutin O -Glycan Golgi apparatus+Endoplasmic reticulum - Tomono et al.: Glycan evolution based on phylogenetic profiling 2 Supplementary Table S1. List of 173 enzymes that are composed of glycosyltransferases and functionally-linked glycan synthetic enzymes UniProt ID Protein Name Categories of Glycan Localization CAZy Class 2 Q16880 2-hydroxyacylsphingosine 1--galactosyltransferase Glycosphingolipid - GT1 O -Glycan, N -Glycan, Glycosphingolipid, P15291 -1,4-galactosyltransferase 1 Golgi apparatus GT7 Proteoglycan O60909 -1,4-galactosyltransferase 2 O -Glycan, N -Glycan, Proteoglycan Golgi apparatus GT7 O -Glycan, N -Glycan, Glycosphingolipid, O60512 -1,4-galactosyltransferase 3 Golgi apparatus GT7 Proteoglycan O60513 -1,4-galactosyltransferase 4 Glycosphingolipid, Proteoglycan Golgi apparatus GT7 O43286 -1,4-galactosyltransferase 5 O -Glycan Golgi apparatus GT7 Q9UBX8 -1,4-galactosyltransferase 6 Glycosphingolipid Golgi apparatus GT7 Q9UBV7 -1,4-galactosyltransferase 7 Proteoglycan Golgi apparatus GT7 Q6L9W6 -1,4-N -acetylgalactosaminyltransferase 3 N -Glycan Golgi apparatus GT7 Q8TDX6 Chondroitin sulfate N -acetylgalactosaminyltransferase 1 Proteoglycan Golgi apparatus GT7 Q8N6G5 Chondroitin sulfate N -acetylgalactosaminyltransferase 2 Proteoglycan Golgi apparatus GT7 Q76KP1 N -acetyl--glucosaminyl-glycoprotein 4--N -acetylgalactosaminyltransferase 1 N -Glycan Golgi apparatus GT7 Q86X52 Chondroitin sulfate synthase 1 Proteoglycan Golgi apparatus GT7, GT31 Q8IZ52 Chondroitin sulfate synthase 2 Proteoglycan Golgi apparatus GT7, GT31 Q70JA7 Chondroitin sulfate synthase 3 Proteoglycan Golgi apparatus GT7, GT31 A0PJZ3 Glucoside xylosyltransferase 2 O -Glycan - GT8 Q8NBI6 Xyloside xylosyltransferase 1 O -Glycan Endoplasmic reticulum GT8 Q4G148 Glucoside xylosyltransferase 1 O -Glycan Golgi apparatus GT8 Q6P4F1 -(1,3)-fucosyltransferase 10 N -Glycan Golgi apparatus GT10 P22083 -(1,3)-fucosyltransferase 4 O -Glycan, Glycosphingolipid Golgi apparatus GT10 Q11128 -(1,3)-fucosyltransferase 5 Glycosphingolipid Golgi apparatus GT10 P51993 -(1,3)-fucosyltransferase 6 Glycosphingolipid Golgi apparatus GT10 Q11130 -(1,3)-fucosyltransferase 7 O -Glycan, Glycosphingolipid Golgi apparatus GT10 Q9Y231 -(1,3)-fucosyltransferase 9 O -Glycan, Glycosphingolipid Golgi apparatus GT10 P21217 Galactoside 3(4)-L-fucosyltransferase Glycosphingolipid Golgi apparatus GT10 P26572 -1,3-mannosyl-glycoprotein 2--N -acetylglucosaminyltransferase N -Glycan Golgi apparatus GT13 Q8WZA1 Protein O -linked-mannose -1,2-N -acetylglucosaminyltransferase 1 O -Glycan Golgi apparatus GT13 Q02742 -1,3-galactosyl-O -glycosyl-glycoprotein -1,6-N -acetylglucosaminyltransferase O -Glycan Golgi apparatus GT14 O95395 -1,3-galactosyl-O -glycosyl-glycoprotein -1,6-N -acetylglucosaminyltransferase 3 O -Glycan Golgi apparatus GT14 Q9P109 -1,3-galactosyl-O -glycosyl-glycoprotein -1,6-N -acetylglucosaminyltransferase 4 O -Glycan Golgi apparatus GT14 Q6ZNI0 -1,3-galactosyl-O -glycosyl-glycoprotein -1,6-N -acetylglucosaminyltransferase 7 O -Glycan Golgi apparatus GT14 Q06430 N -acetyllactosaminide -1,6-N -acetylglucosaminyl-transferase, isoform B Glycosphingolipid Golgi apparatus GT14 Q86Y38 Xylosyltransferase 1 Proteoglycan Golgi apparatus+Endoplasmic reticulum GT14 Q9H1B5 Xylosyltransferase 2 Proteoglycan Golgi apparatus+Endoplasmic reticulum GT14 Q10469 -1,6-mannosyl-glycoprotein 2--N -acetylglucosaminyltransferase N -Glycan Golgi apparatus GT16 Q9BYC5 -(1,6)-fucosyltransferase N -Glycan, Proteoglycan Golgi apparatus GT23 Q8NBJ5 Procollagen galactosyltransferase 1 O -Glycan Endoplasmic reticulum GT25 Q8IYK4 Procollagen galactosyltransferase 2 O -Glycan Endoplasmic reticulum GT25 Q7Z4T8 Putative polypeptide N -acetylgalactosaminyltransferase-like protein 5 O -Glycan Golgi apparatus GT27 Q86SF2 N -acetylgalactosaminyltransferase 7 O -Glycan Golgi apparatus GT27, CBM13 Q10472 Polypeptide N -acetylgalactosaminyltransferase 1 O -Glycan Golgi apparatus GT27, CBM13 Q10471 Polypeptide N -acetylgalactosaminyltransferase 2 O -Glycan Golgi apparatus GT27, CBM13 Q14435 Polypeptide N -acetylgalactosaminyltransferase 3 O -Glycan Golgi apparatus GT27, CBM13 Q8N4A0 Polypeptide N -acetylgalactosaminyltransferase 4 O -Glycan Golgi apparatus GT27, CBM13 Q7Z7M9 Polypeptide N -acetylgalactosaminyltransferase 5 O -Glycan Golgi apparatus GT27, CBM13 Q8NCL4 Polypeptide N -acetylgalactosaminyltransferase 6 O -Glycan Golgi apparatus GT27, CBM13 Q9HCQ5 Polypeptide N -acetylgalactosaminyltransferase 9 O -Glycan Golgi apparatus GT27, CBM13 Q86SR1 Polypeptide N -acetylgalactosaminyltransferase 10 O -Glycan Golgi apparatus GT27, CBM13 Q8NCW6 Polypeptide N -acetylgalactosaminyltransferase 11 O -Glycan Golgi apparatus GT27, CBM13 Tomono et al.: Glycan evolution based on phylogenetic profiling 3 Supplementary Table S1. List of 173 enzymes that are composed of glycosyltransferases and functionally-linked glycan synthetic enzymes UniProt ID Protein Name Categories of Glycan Localization CAZy Q8IXK2 Polypeptide N -acetylgalactosaminyltransferase
Load more

Recommended publications
  • Bacteria Belonging to Pseudomonas Typographi Sp. Nov. from the Bark Beetle Ips Typographus Have Genomic Potential to Aid in the Host Ecology
    insects Article Bacteria Belonging to Pseudomonas typographi sp. nov. from the Bark Beetle Ips typographus Have Genomic Potential to Aid in the Host Ecology Ezequiel Peral-Aranega 1,2 , Zaki Saati-Santamaría 1,2 , Miroslav Kolaˇrik 3,4, Raúl Rivas 1,2,5 and Paula García-Fraile 1,2,4,5,* 1 Microbiology and Genetics Department, University of Salamanca, 37007 Salamanca, Spain; [email protected] (E.P.-A.); [email protected] (Z.S.-S.); [email protected] (R.R.) 2 Spanish-Portuguese Institute for Agricultural Research (CIALE), 37185 Salamanca, Spain 3 Department of Botany, Faculty of Science, Charles University, Benátská 2, 128 01 Prague, Czech Republic; [email protected] 4 Laboratory of Fungal Genetics and Metabolism, Institute of Microbiology of the Academy of Sciences of the Czech Republic, 142 20 Prague, Czech Republic 5 Associated Research Unit of Plant-Microorganism Interaction, University of Salamanca-IRNASA-CSIC, 37008 Salamanca, Spain * Correspondence: [email protected] Received: 4 July 2020; Accepted: 1 September 2020; Published: 3 September 2020 Simple Summary: European Bark Beetle (Ips typographus) is a pest that affects dead and weakened spruce trees. Under certain environmental conditions, it has massive outbreaks, resulting in attacks of healthy trees, becoming a forest pest. It has been proposed that the bark beetle’s microbiome plays a key role in the insect’s ecology, providing nutrients, inhibiting pathogens, and degrading tree defense compounds, among other probable traits. During a study of bacterial associates from I. typographus, we isolated three strains identified as Pseudomonas from different beetle life stages. In this work, we aimed to reveal the taxonomic status of these bacterial strains and to sequence and annotate their genomes to mine possible traits related to a role within the bark beetle holobiont.
    [Show full text]
  • Enzymatic Encoding Methods for Efficient Synthesis Of
    (19) TZZ__T (11) EP 1 957 644 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: C12N 15/10 (2006.01) C12Q 1/68 (2006.01) 01.12.2010 Bulletin 2010/48 C40B 40/06 (2006.01) C40B 50/06 (2006.01) (21) Application number: 06818144.5 (86) International application number: PCT/DK2006/000685 (22) Date of filing: 01.12.2006 (87) International publication number: WO 2007/062664 (07.06.2007 Gazette 2007/23) (54) ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES ENZYMVERMITTELNDE KODIERUNGSMETHODEN FÜR EINE EFFIZIENTE SYNTHESE VON GROSSEN BIBLIOTHEKEN PROCEDES DE CODAGE ENZYMATIQUE DESTINES A LA SYNTHESE EFFICACE DE BIBLIOTHEQUES IMPORTANTES (84) Designated Contracting States: • GOLDBECH, Anne AT BE BG CH CY CZ DE DK EE ES FI FR GB GR DK-2200 Copenhagen N (DK) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • DE LEON, Daen SK TR DK-2300 Copenhagen S (DK) Designated Extension States: • KALDOR, Ditte Kievsmose AL BA HR MK RS DK-2880 Bagsvaerd (DK) • SLØK, Frank Abilgaard (30) Priority: 01.12.2005 DK 200501704 DK-3450 Allerød (DK) 02.12.2005 US 741490 P • HUSEMOEN, Birgitte Nystrup DK-2500 Valby (DK) (43) Date of publication of application: • DOLBERG, Johannes 20.08.2008 Bulletin 2008/34 DK-1674 Copenhagen V (DK) • JENSEN, Kim Birkebæk (73) Proprietor: Nuevolution A/S DK-2610 Rødovre (DK) 2100 Copenhagen 0 (DK) • PETERSEN, Lene DK-2100 Copenhagen Ø (DK) (72) Inventors: • NØRREGAARD-MADSEN, Mads • FRANCH, Thomas DK-3460 Birkerød (DK) DK-3070 Snekkersten (DK) • GODSKESEN,
    [Show full text]
  • Evolution of Protein N-Glycosylation Process in Golgi Apparatus
    www.nature.com/scientificreports OPEN Evolution of protein N-glycosylation process in Golgi apparatus which shapes diversity of protein N-glycan Received: 13 October 2016 Accepted: 01 December 2016 structures in plants, animals Published: 11 January 2017 and fungi Peng Wang1, Hong Wang2, Jiangtao Gai1, Xiaoli Tian3, Xiaoxiao Zhang4, Yongzhi Lv1 & Yi Jian1 Protein N-glycosylation (PNG) is crucial for protein folding and enzymatic activities, and has remarkable diversity among eukaryotic species. Little is known of how unique PNG mechanisms arose and evolved in eukaryotes. Here we demonstrate a picture of onset and evolution of PNG components in Golgi apparatus that shaped diversity of eukaryotic protein N-glycan structures, with an emphasis on roles that domain emergence and combination played on PNG evolution. 23 domains were identified from 24 known PNG genes, most of which could be classified into a single clan, indicating a single evolutionary source for the majority of the genes. From 153 species, 4491 sequences containing the domains were retrieved, based on which we analyzed distribution of domains among eukaryotic species. Two domains in GnTV are restricted to specific eukaryotic domains, while 10 domains distribute not only in species where certain unique PNG reactions occur and thus genes harboring these domains are supoosed to be present, but in other ehkaryotic lineages. Notably, two domains harbored by β-1,3 galactosyltransferase, an essential enzyme in forming plant-specific Lea structure, were present in separated genes in fungi and animals, suggesting its emergence as a result of domain shuffling. Genes with new functions emerge continuously throughout the tree of life.
    [Show full text]
  • Aberrant Sialylation in Cancer: Biomarker and Potential Target for Therapeutic Intervention?
    cancers Review Aberrant Sialylation in Cancer: Biomarker and Potential Target for Therapeutic Intervention? Silvia Pietrobono * and Barbara Stecca * Tumor Cell Biology Unit, Core Research Laboratory, Institute for Cancer Research and Prevention (ISPRO), Viale Pieraccini 6, 50139 Florence, Italy * Correspondence: [email protected] (S.P.); [email protected] (B.S.); Tel.: +39-055-7944568 (S.P.); +39-055-7944567 (B.S.) Simple Summary: Sialylation is a post-translational modification that consists in the addition of sialic acid to growing glycan chains on glycoproteins and glycolipids. Aberrant sialylation is an established hallmark of several types of cancer, including breast, ovarian, pancreatic, prostate, colorectal and lung cancers, melanoma and hepatocellular carcinoma. Hypersialylation can be the effect of increased activity of sialyltransferases and results in an excess of negatively charged sialic acid on the surface of cancer cells. Sialic acid accumulation contributes to tumor progression by several paths, including stimulation of tumor invasion and migration, and enhancing immune evasion and tumor cell survival. In this review we explore the mechanisms by which sialyltransferases promote cancer progression. In addition, we provide insights into the possible use of sialyltransferases as biomarkers for cancer and summarize findings on the development of sialyltransferase inhibitors as potential anti-cancer treatments. Abstract: Sialylation is an integral part of cellular function, governing many biological processes Citation: Pietrobono, S.; Stecca, B. including cellular recognition, adhesion, molecular trafficking, signal transduction and endocytosis. Aberrant Sialylation in Cancer: Sialylation is controlled by the levels and the activities of sialyltransferases on glycoproteins and Biomarker and Potential Target for lipids. Altered gene expression of these enzymes in cancer yields to cancer-specific alterations of Therapeutic Intervention? Cancers glycoprotein sialylation.
    [Show full text]
  • Two Arabidopsis Proteins Synthesize Acetylated Xylan Invitro
    The Plant Journal (2014) 80, 197–206 doi: 10.1111/tpj.12643 FEATURED ARTICLE Two Arabidopsis proteins synthesize acetylated xylan in vitro Breeanna R. Urbanowicz, Maria J. Pena*,~ Heather A. Moniz, Kelley W. Moremen and William S. York* Complex Carbohydrate Research Center, University of Georgia, 315 Riverbend Road, Athens, GA 30602, USA Received 4 June 2014; revised 18 July 2014; accepted 1 August 2014; published online 21 August 2014. *For correspondence (e-mails [email protected]; [email protected]). SUMMARY Xylan is the third most abundant glycopolymer on earth after cellulose and chitin. As a major component of wood, grain and forage, this natural biopolymer has far-reaching impacts on human life. This highly acetylated cell wall polysaccharide is a vital component of the plant cell wall, which functions as a molecular scaffold, pro- viding plants with mechanical strength and flexibility. Mutations that impair synthesis of the xylan backbone give rise to plants that fail to grow normally because of collapsed xylem cells in the vascular system. Phenotypic analysis of these mutants has implicated many proteins in xylan biosynthesis; however, the enzymes directly responsible for elongation and acetylation of the xylan backbone have not been unambiguously identified. Here we provide direct biochemical evidence that two Arabidopsis thaliana proteins, IRREGULAR XYLEM 10–L (IRX10-L) and ESKIMO1/TRICOME BIREFRINGENCE 29 (ESK1/TBL29), catalyze these respective processes in vi- tro. By identifying the elusive xylan synthase and establishing ESK1/TBL29 as the archetypal plant polysaccha- ride O-acetyltransferase, we have resolved two long-standing questions in plant cell wall biochemistry.
    [Show full text]
  • Multiplexed Engineering Glycosyltransferase Genes in CHO Cells Via Targeted Integration for Producing Antibodies with Diverse Complex‑Type N‑Glycans Ngan T
    www.nature.com/scientificreports OPEN Multiplexed engineering glycosyltransferase genes in CHO cells via targeted integration for producing antibodies with diverse complex‑type N‑glycans Ngan T. B. Nguyen, Jianer Lin, Shi Jie Tay, Mariati, Jessna Yeo, Terry Nguyen‑Khuong & Yuansheng Yang* Therapeutic antibodies are decorated with complex‑type N‑glycans that signifcantly afect their biodistribution and bioactivity. The N‑glycan structures on antibodies are incompletely processed in wild‑type CHO cells due to their limited glycosylation capacity. To improve N‑glycan processing, glycosyltransferase genes have been traditionally overexpressed in CHO cells to engineer the cellular N‑glycosylation pathway by using random integration, which is often associated with large clonal variations in gene expression levels. In order to minimize the clonal variations, we used recombinase‑mediated‑cassette‑exchange (RMCE) technology to overexpress a panel of 42 human glycosyltransferase genes to screen their impact on antibody N‑linked glycosylation. The bottlenecks in the N‑glycosylation pathway were identifed and then released by overexpressing single or multiple critical genes. Overexpressing B4GalT1 gene alone in the CHO cells produced antibodies with more than 80% galactosylated bi‑antennary N‑glycans. Combinatorial overexpression of B4GalT1 and ST6Gal1 produced antibodies containing more than 70% sialylated bi‑antennary N‑glycans. In addition, antibodies with various tri‑antennary N‑glycans were obtained for the frst time by overexpressing MGAT5 alone or in combination with B4GalT1 and ST6Gal1. The various N‑glycan structures and the method for producing them in this work provide opportunities to study the glycan structure‑and‑function and develop novel recombinant antibodies for addressing diferent therapeutic applications.
    [Show full text]
  • Induced Structural Changes in a Multifunctional Sialyltransferase
    Biochemistry 2006, 45, 2139-2148 2139 Cytidine 5′-Monophosphate (CMP)-Induced Structural Changes in a Multifunctional Sialyltransferase from Pasteurella multocida†,‡ Lisheng Ni,§ Mingchi Sun,§ Hai Yu,§ Harshal Chokhawala,§ Xi Chen,*,§ and Andrew J. Fisher*,§,| Department of Chemistry and the Section of Molecular and Cellular Biology, UniVersity of California, One Shields AVenue, DaVis, California 95616 ReceiVed NoVember 23, 2005; ReVised Manuscript ReceiVed December 19, 2005 ABSTRACT: Sialyltransferases catalyze reactions that transfer a sialic acid from CMP-sialic acid to an acceptor (a structure terminated with galactose, N-acetylgalactosamine, or sialic acid). They are key enzymes that catalyze the synthesis of sialic acid-containing oligosaccharides, polysaccharides, and glycoconjugates that play pivotal roles in many critical physiological and pathological processes. The structures of a truncated multifunctional Pasteurella multocida sialyltransferase (∆24PmST1), in the absence and presence of CMP, have been determined by X-ray crystallography at 1.65 and 2.0 Å resolutions, respectively. The ∆24PmST1 exists as a monomer in solution and in crystals. Different from the reported crystal structure of a bifunctional sialyltransferase CstII that has only one Rossmann domain, the overall structure of the ∆24PmST1 consists of two separate Rossmann nucleotide-binding domains. The ∆24PmST1 structure, thus, represents the first sialyltransferase structure that belongs to the glycosyltransferase-B (GT-B) structural group. Unlike all other known GT-B structures, however, there is no C-terminal extension that interacts with the N-terminal domain in the ∆24PmST1 structure. The CMP binding site is located in the deep cleft between the two Rossmann domains. Nevertheless, the CMP only forms interactions with residues in the C-terminal domain.
    [Show full text]
  • Sialyltransferase of the 13762 Rat Mammary Ascites Tumor Cells1
    [CANCER RESEARCH 44, 1148-1152, March 1984] Sialyltransferase of the 13762 Rat Mammary Ascites Tumor Cells1 ThérèsePrattand Anne P. Sherblom2 Department of Biochemistry, University of Maine, Orano, Maine 04469 ABSTRACT The MAT-B1 and MAT-C1 sublines of the 13762 rat mammary adenocarcinoma are a suitable system for studying sialic acid The MAT-B1 and MAT-C1 ascites sublines of the 13762 rat metabolism. The 2 cell lines, originally derived from the same mammary adenocarcinoma differ in morphology, agglutinability solid tumor, show marked differences in ability to be transplanted with concanavalin A, and xenotransplantability. Both cell lines into mice, agglutinability with concanavalin A, and total sialic acid contain a major mucin-type glycoprotein, but the MAT-C1 (xen- content (19). Greater than 70% of the protein-bound sialic acid otransplantable) subline contains a 3-fold-greater content of sialic in both cell lines is due to a high-molecular-weight mucin-type acid on the glycoprotein than does the MAT-B1 (nonxeno- glycoprotein, ASGP-1 (16). The 0-linked chains have a core transplantable) subline. structure Gal(01-»4)GlcNAc(01-»6)[Gal(|31-»3)]GalNAc3 where The present work indicates that whole cells of both lines both galactose residues may be substituted with sialic acids incorporate radioactivity from labeled CMP-sialic acid into a linked («2—>3).4TheMAT-C1 subline contains much more of component which comigrates with the major glycoprotein by disialylated hexasaccharide than does the MAT-B1 subline,4 sodium dodecyl sulfate polyacrylamide gel electrophoresis, and whereas the MAT-B1 oligosaccharides are predominantly neutral that label incorporated by MAT-B1 cells is released by alkaline- but may contain sulfate as well as sialic acid (17).
    [Show full text]
  • Mannosyltransferase
    Ribeiro et al. Parasites & Vectors (2019) 12:60 https://doi.org/10.1186/s13071-019-3305-2 SHORT REPORT Open Access Mannosyltransferase (GPI-14) overexpression protects promastigote and amastigote forms of Leishmania braziliensis against trivalent antimony Christiana Vargas Ribeiro†, Bruna Fonte Boa Rocha†, Douglas de Souza Moreira, Vanessa Peruhype-Magalhães and Silvane Maria Fonseca Murta* Abstract Background: Glycosylphosphatidylinositol is a surface molecule important for host-parasite interactions. Mannosyltransferase (GPI-14) is an essential enzyme for adding mannose on the glycosylphosphatidyl group. This study attempted to overexpress the GPI-14 gene in Leishmania braziliensis to investigate its role in the antimony- resistance phenotype of this parasite. Results: GPI-14 mRNA levels determined by quantitative real-time PCR (qRT-PCR) showed an increased expression in clones transfected with GPI-14 compared to its respective wild-type line. In order to investigate the expression profile of the surface carbohydrates of these clones, the intensity of the fluorescence emitted by the parasites after concanavalin-A (a lectin that binds to the terminal regions of α-D-mannosyl and α-D-glucosyl residues) treatment was analyzed. The results showed that the clones transfected with GPI-14 express 2.8-fold more mannose and glucose residues than those of the wild-type parental line, indicating effective GPI-14 overexpression. Antimony susceptibility tests using promastigotes showed that clones overexpressing the GPI-14 enzyme are 2.4- and 10.5- fold more resistant to potassium antimonyl tartrate (SbIII) than the parental non-transfected line. Infection analysis using THP-1 macrophages showed that amastigotes from both GPI-14 overexpressing clones were 3-fold more resistant to SbIII than the wild-type line.
    [Show full text]
  • Using Glyco-Engineering to Produce Therapeutic Proteins
    Assigned Reading: Using glyco-engineering to produce therapeutic proteins. Dicker M and Strasser R Expert Opin. Biol. Ther. (2015) 15:1501. Advances in the production of human therapeutic proteins in yeasts and filamentous fungi Gerngross TU, Nat. Biotech, 22:1409 (2004) Glycan Engineering for Cell and Developmental Biology Griffin ME and Hsieh-Wilson LC Cell Chem Biol, 23:108 (2016) Expert Opinion on Biological Therapy ISSN: 1471-2598 (Print) 1744-7682 (Online) Journal homepage: http://www.tandfonline.com/loi/iebt20 Using glyco-engineering to produce therapeutic proteins Martina Dicker & Richard Strasser To cite this article: Martina Dicker & Richard Strasser (2015) Using glyco-engineering to produce therapeutic proteins, Expert Opinion on Biological Therapy, 15:10, 1501-1516, DOI: 10.1517/14712598.2015.1069271 To link to this article: http://dx.doi.org/10.1517/14712598.2015.1069271 Published online: 14 Jul 2015. Submit your article to this journal Article views: 345 View related articles View Crossmark data Citing articles: 1 View citing articles Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=iebt20 Download by: [University of California, San Diego] Date: 17 May 2016, At: 09:13 Review Using glyco-engineering to produce therapeutic proteins † Martina Dicker & Richard Strasser 1. Introduction University of Natural Resources and Life Sciences, Department of Applied Genetics and Cell Biology, Vienna, Austria 2. N-glycosylation of proteins 3. What are the targets for Introduction: Glycans are increasingly important in the development of N-glycan-engineering? new biopharmaceuticals with optimized efficacy, half-life, and antigenicity. 4. O-glycosylation of proteins Current expression platforms for recombinant glycoprotein therapeutics typically do not produce homogeneous glycans and frequently display non- 5.
    [Show full text]
  • LN-EPC Vs CEPC List
    Supplementary Information Table 5. List of genes upregulated on LN-EPC (LCB represents the variation of gene expression comparing LN-EPC with CEPC) Gene dystrophin (muscular dystrophy, Duchenne and Becker types) regulator of G-protein signalling 13 chemokine (C-C motif) ligand 8 vascular cell adhesion molecule 1 matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) chemokine (C-C motif) ligand 2 solute carrier family 2 (facilitated glucose/fructose transporter), member 5 eukaryotic translation initiation factor 1A, Y-linked regulator of G-protein signalling 1 ubiquitin D chemokine (C-X-C motif) ligand 3 transcription factor 4 chemokine (C-X-C motif) ligand 13 (B-cell chemoattractant) solute carrier family 7, (cationic amino acid transporter, y+ system) member 11 transcription factor 4 apolipoprotein D RAS guanyl releasing protein 3 (calcium and DAG-regulated) matrix metalloproteinase 1 (interstitial collagenase) DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked /// DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked transcription factor 4 regulator of G-protein signalling 1 B-cell linker interleukin 8 POU domain, class 2, associating factor 1 CD24 antigen (small cell lung carcinoma cluster 4 antigen) Consensus includes gb:AK000168.1 /DEF=Homo sapiens cDNA FLJ20161 fis, clone COL09252, highly similar to L33930 Homo sapiens CD24 signal transducer mRNA. /FEA=mRNA /DB_XREF=gi:7020079 /UG=Hs.332045 Homo sapiens cDNA FLJ20161 fis, clone COL09252, highly similar to L33930 Homo sapiens CD24 signal transducer mRNA
    [Show full text]
  • N-Glycosylation in Sugarcane
    Genetics and Molecular Biology, 24 (1-4), 231-234 (2001) N-glycosylation in sugarcane Ivan G. Maia1,2 and Adilson Leite1* Abstract The N-linked glycosylation of secretory and membrane proteins is the most complex posttranslational modification known to occur in eukaryotic cells. It has been shown to play critical roles in modulating protein function. Although this important biological process has been extensively studied in mammals, much less is known about this biosynthetic pathway in plants. The enzymes involved in plant N-glycan biosynthesis and processing are still not well defined and the mechanism of their genetic regulation is almost completely unknown. In this paper we describe our first attempt to understand the N-linked glycosylation mechanism in a plant species by using the data generated by the Sugarcane Expressed Sequence Tag (SUCEST) project. The SUCEST database was mined for sugarcane gene products potentially involved in the N-glycosylation pathway. This approach has led to the identification and functional assignment of 90 expressed sequence tag (EST) clusters sharing significant sequence similarity with the enzymes involved in N-glycan biosynthesis and processing. The ESTs identified were also analyzed to establish their relative abundance. INTRODUCTION tide chain (Hubbard and Ivatt, 1981). Immediately after the transfer, Glc Man GlcNAc undergoes trimming of the In plants, as in other eukaryotes, most of the soluble 3 9 2 glucose (Glc) and some of the mannose (Man) residues, and membrane bound proteins that are synthesized on poly- first in the ER and then in the Golgi apparatus (Figure 2A; ribosomes associated with the endoplasmic reticulum (ER) for a review see Herscovics, 1999), giving rise to high-ma- are glycoproteins, including those proteins which will later nnose-type N-glycans containing from five to nine ma- be exported to the Golgi apparatus, lysosomes, plasma nnose residues.
    [Show full text]